Macrolide Pharmaceuticals picks up $22 mln
Newton, Massachusetts-based Macrolide Pharmaceuticals, a new company focused on developing novel antibiotics, has secured $22 million in Series A funding. The investors were Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne.
4 March 2015•3 mins read
